source
- Podcast interview challenges the scientific basis of blue zones after 25 years of hypeIn a recent First Opinion podcast, Eric Topol and Shelley Wood discuss the rise of the blue zone concept over the past quarter century. They note that the idea began with isolated communities said…
- Sun Pharma’s $12 billion Organon deal signals global push but India still faces R&D hurdlesSun Pharma is close to completing a nearly $12 billion purchase of Organon, which would lift the Indian group into the world’s top‑25 pharmaceutical companies and expand its footprint to about 150…